慢性胰腺炎3例临床及内镜诊治分析
收稿日期: 2021-06-10
网络出版日期: 2022-02-11
Clinical and endoscopic diagnosis and treatment of 3 cases of chronic pancreatitis
Received date: 2021-06-10
Online published: 2022-02-11
目的 探讨由基因或结构异常所致慢性胰腺炎患儿的临床特点,及其经内镜逆行胰胆管造影术(ERCP)诊治的临床疗效。方法 回顾分析2020年7-10月采用ERCP治疗的3例慢性胰腺炎患儿的临床资料。结果 3例慢性胰腺炎患儿,2例男性、1例女性,年龄为11岁1例,12岁2例,主要临床症状均为慢性腹痛,无胰腺内外分泌功能不全的表现。2例患儿由基因变异所致,分别为SPINK1、LPL基因变异;1例由结构异常所致,为胰管先天发育异常,胰体部胰管呈分支状。3例患儿常规治疗无效,实施ERCP治疗,通过取出结石、清理胰管、放置支架,以改善引流,缓解胰管压力。术后2例患儿的胰酶均恢复正常,腹痛缓解;1例术后胰酶增高,3天后恢复正常。结论 由基因或结构异常所致儿童慢性胰腺炎行ERCP诊治安全有效。
关键词: 慢性胰腺炎; 基因变异; 胰腺解剖结构异常; 内镜下逆行胰胆管造影术; 儿童
邹标 , 刘圣烜 , 覃华 , 黄志华 , 舒赛男 . 慢性胰腺炎3例临床及内镜诊治分析[J]. 临床儿科杂志, 2022 , 40(2) : 144 -148 . DOI: 10.12372/jcp.2022.21e0866
Objective To evaluate the clinical characteristics of children with chronic pancreatitis caused by genetic and structural abnormalities and the clinical efficacy of endoscopic retrograde cholangiopancreatography (ERCP). Methods The clinical data of 3 children with chronic pancreatitis treated with ERCP from July to October in 2020 were retrospectively analyzed. Results There were 3 children (2 boys and 1 girl) with chronic pancreatitis. One patient was 11 years old and the other two were 12 years old. The main clinical symptoms were chronic abdominal pain without manifestation of pancreatic secretion insufficiency. Two patients were caused by gene variation, which were SPINK1 and LPL gene variation respectively. One patient was caused by structural abnormality, and the pancreatic duct was bifurcated in the body of the pancreas, which was considered as congenital abnormal development of the pancreatic duct. Three children were treated with ERCP after conventional treatment failed. By removing the stones, cleaning the pancreatic duct, placing stents, improving drainage and relieving the pressure of the pancreatic duct, the trypsin levels in 2 patients were restored to normal and the abdominal pain was relieved. The trypsin levels were increased in 1 patient after operation and returned to normal 3 days later. Conclusions ERCP is safe and effective in diagnosis and treatment of childhood chronic pancreatitis caused by genetic or structural abnormalities.
| [1] | McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of vater: a preliminary report[J]. Ann Surg, 1968, 167(5):752-756. |
| [2] | Keil R, Drábek J, Lochmannová J, et al. ERCP in infants, children, and adolescents-Different roles of the methods in different age groups[J]. PLoS One, 2019, 14(1):e0210805. |
| [3] | Barakat MT, Gugig R, Imperial J, et al. Fluoroscopy time during endoscopic retrograde cholangiopancreatography performed for children and adolescents is significantly higher with low-volume endoscopists[J]. J Pediatr Gastroenterol Nutr. 2021, 72(2):244-249. |
| [4] | Deng Z, Zeng J, Lv C, et al. Prevalence and factors associated with post-endoscopic retrograde cholangio-pancreatography pancreatitis in children[J]. Dig Dis Sci, 2021, 66(1):224-230. |
| [5] | Barakat MT, Cholankeril G, Gugig R, et al. Nationwide evolution of pediatric endoscopic retrograde cholangio-pancreatography indications, utilization, and readmissions over time[J]. J Pediatr, 2021, 232:159-165. |
| [6] | Suzuki M, Minowa K, Isayama H, Shimizu T. Acute recurrent and chronic pancreatitis in children[J]. Pediatr Int, 2021, 63(2):137-149. |
| [7] | Bai HX, Lowe ME, Husain SZ. What have we learned about acute pancreatitis in children?[J]. J Pediatr Gastroenterol Nutr, 2011, 52(3):262-270. |
| [8] | Benjamin O, Lappin SL. Chronic Pancreatitis. 2021 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021. |
| [9] | Abu-El-Haija M, El-Dika S, Hinton A, et al. Acute pancreatitis admission trends: a national estimate through the kids' inpatient database[J]. J Pediatr, 2018, 194:147-151. |
| [10] | Bertin C, Pelletier AL, Vullierme MP, et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations[J]. Am J Gastroenterol, 2012, 107(2):311-317. |
| [11] | Usatin D, Fernandes M, Allen IE, et al. Complications of endoscopic retrograde cholangiopancreatography in pediatric patients; a systematic literature review and meta-analysis[J]. J Pediatrm 2016, 179:160-165. |
| [12] | Mercier C, Pioche M, Albuisson E, et al. Safety of endoscopic retrograde cholangiopancreatography in the pediatric population: a multicenter study[J]. Endoscopy, 2021, 53(6):586-594. |
| [13] | Boulling A, Le Maréchal C, Trouvé P, et al. Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene[J]. Eur J Hum Genet, 2007, 15(9):936-942. |
| [14] | Kaneko K, Nagasaki Y, Furukawa T, et al. Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis[J]. J Hum Genet, 2001, 46(5):293-7. |
| [15] | Lin TK, Pathak SJ, Hornung LN, et al. Clinical outcomes following therapeutic endoscopic retrograde cholangiopancreatography in children with pancreas divisum[J]. J Pediatr Gastroenterol Nutr, 2021, 72(2):300-305. |
| [16] | Radenkovic D, Bajec D, Ivancevic N, et al. D-dimer in acute pancreatitis: a new approach for an early assessment of organ failure[J]. Pancreas, 2009, 38(6):655-660. |
| [17] | Troendle DM, Barth BA. ERCP can be safely and effectively performed by a pediatric gastroenterologist for choledocholithiasis in a pediatric facility[J]. J Pediatr Gastroenterol Nutr, 2013, 57(5):655-658. |
| [18] | Vue PM, McFann K, Narkewicz MR. Genetic mutations in pediatric pancreatitis[J]. Pancreas, 2016, 45(7):992-996. |
| [19] | Ma Y, Ooi TC, Liu MS, et al. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform[J]. J Lipid Res, 1994, 35(6):1066-1075. |
/
| 〈 |
|
〉 |